Alan F. Schatzberg: 2012/13 Anna-Monika Prize recipient

Nov 27, 2013

The Anna-Monika Prize is awarded bi-annually to clinical scientists who have made major contributions to the understanding of the underlining neurobiological mechanisms of depression and who have advanced the pharmacological options for affective disorders. In 2013, the Anna-Monika-Foundation was again privileged to honor a leading researcher for his groundbreaking work in the field.

This year’s Anna-Monika award winner is Prof. Alan F. Schatzberg, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, USA.

Prof. Schatzberg received the prize for his outstanding research into new therapy approaches, especially for the treatment of delusional depression. He is one of the leading North American clinical and scientific psychiatrists. In his research work, he focuses on the interactions between the stress hormone (cortisol) system and dopamine metabolism, both on a basic science basis and in clinical studies. A special merit of Prof. Schatzberg’s work is the early recognition of the significance of antiglucocorticoid therapies, for example with mifepristone (RU486), and their possible introduction into psychiatric practice. This research approach implemented by Prof. Schatzberg and his group was adopted by a number of companies and is undergoing Phase III clinical trials. In addition, Prof. Schatzberg has supported the use of antiglucocorticoid therapeutic methods by systematic neurobiological research, including neuroendocrine studies, genetics, brain imaging as well as studies of cognition and its relationship to cortisol activity. Prof. Schatzberg’s work has contributed both to a better understanding of the pathophysiology of severe depression disorders and to the development of novel treatment approaches.

Anna-Monika Foundation »

Comments are closed.